全球的胰島素幫浦（外部用）市場

全球的胰島素幫浦（外部用）市場 是由出版商Global Industry Analysts, Inc.在2010年10月所出版的。 這份英文市場調查報告書包含Pages: 150 價格從美金4500起跳。

簡介

本報告書內容包括:糖尿病和胰島素的概說、外部用胰島素幫浦的產品概要、技術趨勢、產品革新趨勢、全球市場的預測、及全球各國的各國市場趨勢、內容綱要摘記如下:

第1章 介紹、調查方法及產品的定義

第2章 業界概要

• 糖尿病罹患率的增加
• 糖尿病管理的胰島素療法
• 胰島素幫浦：胰島素注射的代用品
• 現在及未來分析
• 競爭情境
• 新加入組的嚴苛市場

第3章 市場趨勢和課題

• 嵌入式胰島素幫浦：進行技術
• 革新的特長為市場擴大
• 併用產品
• 保證期滿：新的機會
• 客戶滿意度
• 胰島素幫浦訓練
• 複雜的軟體使得高齡者的使用困難　其他

第4章 糖尿病和胰島素：概要

• 糖尿病
• 糖尿病的風險因素
• 糖尿病的種類
• 長期的合併症
• 血糖值檢查
• 胰島素
• 胰島素治療的目標
• 胰島素給藥系統
• 胰島素給藥技術

第5章 產品概要

• 胰島素幫浦的發展
• 胰臟的複製品
• 優點
• 胰島素幫浦的構成部品
• 胰島素幫浦的功能
• 胰島素幫浦的給藥率
• 使用導覽
• 使用所伴隨的缺點和風險　其他

第6章 產品革新和引進

第7章 近年的產品技術革新和引進

第8章 近年的業界活動

第9章 企業活動

第10章 加入企業

第11章 全球市場展望

第12章 美國

第13章 歐洲

• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 其他

第14章 其他各國

企業介紹：18家（包含事業部・子公司21家）

目錄

Abstract

This report analyzes the worldwide markets for Insulin Pumps (External) in US$ Million. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2007 through 2015. A six-year historic analysis is also provided for these markets. The report profiles 18 companies including many key and niche players such as Animas Corporation, Debiotech S.A., F. Hoffmann-La Roche, Ltd., Disetronic Medical Systems, Inc, Insulet Corporation, Medtronic Diabetes, Nilimedix Ltd, Nipro Diabetes Systems, Sooil Development Co. Ltd., and Starbridge Systems Ltd. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Table of Contents

1. INTRODUCTION, METHODOLOGY &PRODUCT DEFINITIONS 1

• Study Reliability and Reporting Limitations1
• Disclaimers2
• Data Interpretation & Reporting Level2
• Quantitative Techniques & Analytics3
• Product Definitions and Scope of Study3

2. INDUSTRY OVERVIEW 4

• Increasing Diabetes Prevalence - A Major Growth Propeller4
• Insulin Therapy for Diabetes Management4
• Insulin Pumps: The Convenient Substitute for InsulinInjection5
• Current and Future Analysis5
• The United States - The Largest Market for ExternalInsulin Pumps5
• European Market Characterized by Less Pump Users6
• Competitive Scenario6
• Table 1: World Insulin Pumps Market by LeadingPlayers (2009): Market Share Breakdown forMedtronic, Roche,Insulet and Others(includes corresponding Graph/Chart)6
• Tough Ground for New Entrants7

3. MARKET TRENDS AND ISSUES 8

• Implantable Insulin Pumps: Emerging Technologyin the Insulin Pump Market8
• Innovative Features Spruce Up the Marketfor Insulin Pumps8
• Combination Products in Rage9
• Expiry of Warranty Provides New Opportunitiesto Insulin Pump Makers10
• Customer Satisfaction: Crucial to Stay Competitive10
• Insulin Pump Training - Not Receiving Adequate Attention11
• Complicated Insulin Pump Software Makes PumpUse Difficult for the Aged11
• Debate On Superiority of Pump Therapy OverMDI Continues11
• Teenagers Outdo Adults in Controlling Diabetes11

4. DIABETES & INSULIN - AN ABSTRACT 12

• Diabetes - A Fatal Disease12
• Risk Factors for Diabetes12
• Types of Diabetes12
• Long Term Complications of Diabetes13
• Testing Sugar Levels: Easy and Accurate13
• Insulin13
• Pancreas: The Main Source of Insulin in Human Body13
• Types of Insulin14
• Types of Insulin & Onset of Action14
• Goal of Insulin Therapy14
• Insulin Delivery Systems15
• a. Syringes15
• b. Insulin Pens15
• c. Jet Injectors16
• d. Tablets16
• e. External Insulin Pumps16
• Insulin Delivery Technologies16

5. PRODUCT OVERVIEW 17

• Evolution of Insulin Pumps17
• Insulin Pump - A Replica of Pancreas17
• Advantages17
• More Accurate and Consistent17
• Enhances Blood Sugar Control in Pediatric Patients18
• Adjusting Time Zones While Traveling18
• Improves Quality of Life18
• Components of Insulin Pump18
• How Does an Insulin Pump Work?19
• Insulin Pump Delivery Rates19
• Guidelines for Insulin Pump Usage19
• Disadvantages/Risks Involved in the Usage of Insulin Pumps20
• High Cost20
• High Involvement20
• Diabetic Ketoacidosis Risk21
• Glucose Testing at Regular Intervals21
• Regular Rotation of Infusion Set21
• Carrying Back-up Kit21
• Regular Refilling of Pump21
• Lantus: A Threat to Insulin Pump Manufacturers21
• Centers for Medicare & Medicaid Services (CMS):Funding Organizations22

6. PRODUCT INNOVATIONS/INTRODUCTIONS 23

• JDRF Develops Novel Technology for Type 1 Diabetes23
• Johnson & Johnson Medical India to Unveil InsulinPumps in India23
• Debiotech and STMicroelectronics Introduced FirstPrototype of a Miniaturized, Disposable Insulin Nanopump23
• ROCHE Launches Accu-Chek Spirit23
• Smith Medical Launches Cozmo in China24
• Industrial Scholar Devises Wristwatch Insulin Pump24
• Medtronic Unveils Arabic Language Insulin Pump24
• Medtronic Launches New Diabetes Monitoring System24

7. PRODUCT INNOVATIONS/INTRODUCTIONS INTHE RECENT PAST - A PERSPECTIVE BUILDER 25

• Debiotech Unveils Miniaturized Insulin Nanopump(tm)25
• Roche Diagnostics Introduces New Insulin Pump System25
• Medtronic Releases New Diabetes Device25
• SpectRx Unveils SimpleChoice Infusion Sets25
• Nipro Diabetes Unveils Amigo(r) Insulin Pump25
• SpectRx Introduces New Series of Insulin Pumps26
• New OmniPod Insulin Management System from Insulet26
• New 1250 Insulin Pumps from Animas26
• Smiths Medical Launches Insulin Pumps in Germany27
• Becton, Dickinson Unveils the First Intelligent Pump27
• Medtronic Rolls Out New Pump Systems27
• Accu-Science Launches New Insulin Pumps in Ireland27
• New Insulin Pump Infusion Sets from SpectRx27
• Roche Expands Accu-Chek Product Line28
• Cozmo(r) Insulin Pump Technology from Smiths28
• Medtronic Unveils Paradigm 512 and 71228
• SpectRx Launches Disposable Infusion Set28

8. RECENT INDUSTRY ACTIVITY 29

• JDRF Enters into Partnership with Animas29
• JDRF Collaborates with BD29
• Nilimedix Inks Strategic Distribution Agreementwith Sinopharm29
• Roche Takes Over Medingo30
• Insulet Inks Exclusive Distribution Agreement withYpsomed30
• NiliMedix Obtains CE Mark Certification for NiliPatchDisposable Insulin Pump30
• Medingo Obtains FDA Approval for MarketingInsulin Micropump30
• Eli Lilly and Medtronic Enter into a StrategicMarketing Alliance30
• Medtronic Acquires Certain Assets from PreciSense31
• Insulet Wins CE Mark Approval for OmniPod(r) InsulinManagement System31
• DexCom and Animas Amend Insulin PumpJoint Development Deal31
• Medtronic Inaugurates Diabetes Therapy Managementand Education Center31
• Smiths Medical Ceases Insulin Pumps Sale,Exits Diabetes Business32
• Alere Medical Acquires Matria Healthcare32
• Smiths Medical Acquires Zhejiang Zheda MedicalInstrument32
• Animas Partners with DexCom32
• Animas Recalls Insulin Pumps with Faulty Battery Cap33
• VitalCare Announces Launch of Diabetes TreatmentCenters Across the US33
• Novo Nordisk Receives FDA Approval for PediatricApplication of NovoLog(r)33

9. CORPORATE ACTIVITY IN THE RECENT PAST - A PERSPECTIVE BUILDER 34

• Insulet Inks Agreement with DexCom34
• Medtronic Partners with LifeScan34
• Phluid Corporation Inks Agreement with Syprosoft34
• Insulet Partners with Flextronics34
• Medco Absorbs PolyMedica34
• Debiotech Allies with STMicroelectronics34
• NiliMedix Seeks FDA Approval35
• NiliMedix Attains CE Approval35
• NationsHealth Pockets Diabetes Care & Education35
• SpectRx, Inc. Divests Insulin Pump Business35
• Medtronic Obtains FDA Clearance for MiniMedParadigm(r) Diabetes Device35
• FDA Approves Smiths Medical' s Updated CozMoreSystem35
• Matria Healthcare Acquires CorSolutions36
• Johnson & Johnson Acquires Animas36
• MiniMed Signs an Agreement with Smiths Medical36
• Starbridge Collaborates with Medical House Products36
• Medtronic Extends Educational Support forDiabetes Management37
• ADA Calls the Government to Rescind Cuts toMaine Care37
• Insulet Partners with Solectron37
• Animas' IR 1250 Pump Gains FDA Approval38
• Nilimedix Awaits Grant from Chief Scientist38
• Animas Recalls Its Newly Released Insulin Pumps38
• Animas Teams Up with Debiotech38
• Deltec Turns Into Smiths Medical39
• Smiths' Products Gain FDA Approval39
• Cigna Detaches Dana39
• Smiths Collaborates with TheraSense39
• Animas' Insulin Pumps Receive Nod fromHealth Canada40
• Smiths Partners with Abbott40
• Cleo 90 Receives FDA Approval40
• Animas' Insulin Pump Receives the Approval of IsraeliGovernment40
• Animas Relocates Headquarters40
• FDA Bans Disetronic in the US40
• Animas Expands41
• Medtronic Retracts Infusion Sets41
• Animas Acquires Cygnus41
• Novo Nordisk Signs an Agreement with Medtronic41
• Roche Acquires Disetronic42

10. FOCUS ON KEY PLAYERS 43

• Animas Corp. (USA)43
• Debiotech S.A. (Switzerland)43
• F. Hoffmann-La Roche, Ltd. (Switzerland)43
• Disetronic Medical Systems, Inc. (USA)44
• Insulet Corporation (USA)44
• Medtronic Diabetes (USA)44
• Nilimedix Ltd (Israel)45
• Nipro Diabetes Systems (USA)45
• Sooil Development Co. Ltd. (Korea)45
• Starbridge Systems Ltd. (UK)45

11. GLOBAL MARKET PERSPECTIVE 46

• Table 2: World Recent Past, Current & Future Analysisfor Insulin Pumps (External) by Geographic Region -US, Europe, and Rest of World Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Millionfor Years 2007 through 2015 (includes corresponding Graph/Chart)46
• Table 3: World Historic Review for Insulin Pumps(External) by Geographic Region - US, Europe,and Rest of World Markets Independently Analyzedwith Annual Sales Figures in US$ Million forYears 2001 through 2006 (includes correspondingGraph/Chart)47
• Table 4: World 11-Year Perspective for InsulinPumps by Geographic Region - PercentageBreakdown of Dollar Sales for US, Europe, andRest of World Markets for2005, 2010 & 2015(includes corresponding Graph/Chart)48

12. THE UNITED STATES 49

A. Market Analysis 49

• External Insulin Pumps: A Key Mechanism forInsulin Delivery49
• Surging Diabetic Population Keeps Demand Tickingfor Insulin Pumps49
• Table 5: Diabetes Prevalence in the US by Type:2008 (includes corresponding Graph/Chart)50
• Competitive Scenario50
• Table 6: US Insulin Pumps Market by LeadingPlayers (2008): Market Share Breakdownof for Medtronic, Animas, Insulet, and Others(includes corresponding Graph/Chart)50
• Major Insulin Pump Systems: A Comparison50

B. Market Analytics 51

• Table 7: The US Recent Past, Current & FutureMarket Analysis for Insulin Pumps (External) -Annual Sales Figures in US$ Million for Years 2007through 2015 (includes correspondingGraph/Chart)51
• Table 8: The US Historic Review for Insulin Pumps (External) Market with Annual Sales Figuresin US$ Million for Years 2001 through 2006(includes corresponding Graph/Chart)51

13. EUROPE 52

A. Market Analysis 52

• Though Late, Insulin Pump Starts Gaining FavorAmong Europeans52

B. Market Analytics 53

• Table 9: European Recent Past, Current & FutureMarket Analysis for Insulin Pumps (External) byGeographic Region - France, Germany, UK, Italy,Spain, and Rest of Europe Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Millionfor Years 2007 through 2015 (includescorresponding Graph/Chart)53
• Table 10: European Historic Review for Insulin Pumps (External) by Geographic Region - France, Germany,Italy, UK, Spain, and Rest of Europe MarketsIndependently Analyzed with Annual Sales Figuresin US$ Million for Years 2001 through 2006(includes corresponding Graph/Chart)54
• Table 11: European 11-Year Perspective for InsulinPumps by Geographic Region - PercentageBreakdown of Dollar Sales for France, Germany,UK, Italy, Spain, and Rest of Europe Marketsfor 2005, 2010 & 2015 (includescorresponding Graph/Chart)55

13a. FRANCE 56

• Market Analysis56
• Table 12: French Recent Past, Current & FutureMarket Analysis for Insulin Pumps (External) -Annual Sales Figures in US$ Million forYears 2007 through 2015 (includescorresponding Graph/Chart)56
• Table 13: French Historic Review for Insulin Pumps (External) Market with Annual Sales Figuresin US$ Million for Years 2001 through 2006(includes corresponding Graph/Chart)57

13b. GERMANY 58

• Market Analysis58
• Table 14: German Recent Past, Current & FutureMarket Analysis for Insulin Pumps (External) -Annual Sales Figures in US$ Million for Years 2007through 2015 (includes corresponding Graph/Chart)58
• Table 15: German Historic Review for Insulin Pumps (External) Market with Annual Sales Figuresin US$ Million for Years 2001 through 2006(includes corresponding Graph/Chart)59

13c. ITALY 60

• Market Analysis60
• Table 16: Italian Recent Past, Current & FutureMarket Analysis for Insulin Pumps (External) -Annual Sales Figures in US$ Million for Years 2007through 2015 (includes corresponding Graph/Chart)60
• Table 17: Italian Historic Review for Insulin Pumps (External) Market with Annual Sales Figuresin US$ Million for Years 2001 through 2006(includes corresponding Graph/Chart)61

13d. THE UNITED KINGDOM 62

A. Market Analysis 62

• Current and Future Analysis62
• INPUT (The Insulin Pump Therapy Group)62
• NICE (National Institute of ClinicalExcellence)62

B. Market Analytics 63

• Table 18: The UK Recent Past, Current & FutureMarket Analysis for Insulin Pumps (External) -Annual Sales Figures in US$ Million for Years 2007through 2015 (includes corresponding Graph/Chart)63
• Table 19: The UK Historic Review for Insulin Pumps (External) Market with Annual Sales Figuresin US$ Million for Years 2001 through 2006(includes corresponding Graph/Chart)64
• 13e.SPAIN65
• Market Analysis65
• Table 20: Spanish Recent Past, Current & FutureMarket Analysis for Insulin Pumps (External) -Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)65
• Table 21: Spanish Historic Review for Insulin Pumps (External) Market with Annual Sales Figuresin US$ Million for Years 2001 through 2006(includes corresponding Graph/Chart)66
• 13f.REST OF EUROPE67

A. Market Analysis 67

• Current and Future Analysis67
• Russia67
• Lack of Awareness: A Major Growth Restraint67

B. Market Analytics 68

• Table 22: Rest of Europe Recent Past, Current &Future Market Analysis for Insulin Pumps (External) -Annual Sales Figures in US$ Million for Years2007 through 2015 (includes corresponding Graph/Chart)68
• Table 23: Rest of Europe Historic Review for InsulinPumps (External) Market with Annual Sales Figuresin US$ Million for Years 2001 through 2006(includes corresponding Graph/Chart)69

14. REST OF WORLD 70

A. Market Analysis 70

• Current and Future Analysis70
• Review of Select Countries/Regions70
• India70
• Insulin Pumps Gather Momentum70
• Medtronic: The Undisputed Market Leader70
• China71
• Overview71
• Competition71
• Brazil71

B. Market Analytics 72

• Table 24: Rest of World Recent Past, Current &Future Market Analysis for Insulin Pumps byProduct - External Insulin Pumps MarketIndependently Analyzed with Annual SalesFigures in US$ Million for Years 2007through 2015 (includes correspondingGraph/Chart)72
• Table 25: Rest of World Historic Review forInsulin Pumps (External) Market withAnnual Sales Figures in US$ Million forYears 2001 through 2006 (includescorresponding Graph/Chart)73

COMPETITION

相關商品